» Articles » PMID: 15542430

Upregulation of CXCR4 is Essential for HER2-mediated Tumor Metastasis

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2004 Nov 16
PMID 15542430
Citations 235
Authors
Affiliations
Soon will be listed here.
Abstract

The receptor tyrosine kinase HER2 enhances tumor metastasis; however, its role in homing to metastatic organs is poorly understood. The chemokine receptor CXCR4 has recently been shown to mediate the movement of malignant cancer cells to specific organs. Here, we show that HER2 enhances the expression of CXCR4, which is required for HER2-mediated invasion in vitro and lung metastasis in vivo. HER2 also inhibits ligand-induced CXCR4 degradation. Finally, a significant correlation between HER2 and CXCR4 expression was observed in human breast tumor tissues, and CXCR4 expression correlated with a poor overall survival rate in patients with breast cancer. These results provide a plausible mechanism for HER2-mediated breast tumor metastasis and establish a functional link between HER2 and CXCR4 signaling pathways.

Citing Articles

The Use of Biologics for Targeting GPCRs in Metastatic Cancers.

McBrien C, OConnell D BioTech (Basel). 2025; 14(1).

PMID: 39982274 PMC: 11843943. DOI: 10.3390/biotech14010007.


Exploring lipidomic profiles and their correlation with hormone receptor and HER2 status in breast cancer.

Qian X, Jin X, He J, Zhang J, Hu S Oncol Lett. 2024; 29(1):34.

PMID: 39512509 PMC: 11542162. DOI: 10.3892/ol.2024.14781.


Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics.

Mavingire N, Moore J, Johnson J, Dwead A, Cropp C, Mechref Y Cancers (Basel). 2024; 16(19).

PMID: 39409883 PMC: 11476348. DOI: 10.3390/cancers16193262.


Development of a highly sensitive platform for protein-protein interaction detection and regulation of T cell function.

Hayashi H, Mak T, Tanaka Y, Kubo Y, Izumida M, Urae R Proc Natl Acad Sci U S A. 2024; 121(33):e2318190121.

PMID: 39106307 PMC: 11331103. DOI: 10.1073/pnas.2318190121.


A Comprehensive Review of HER2 in Cancer Biology and Therapeutics.

Cheng X Genes (Basel). 2024; 15(7).

PMID: 39062682 PMC: 11275319. DOI: 10.3390/genes15070903.